xrimatistirio.com
ELEN
Διαθέσιμο και στα ελληνικά. Δες το στα ελληνικά →
← Back to dashboard
Sarantis logo
SARConsumer Defensive · Household & Personal Products · ΧΑ

Sarantis

€11.32
+0.48(+4.43%)
Close 26/10/2026 · end-of-day price, not real-time

Sarantis (SAR) closed at €11.32 on 26/10/2026, +4.43% on the day. Market cap €718.8m, P/E 14.3, dividend yield 3.49%.

Why it moved today

No published cause yet.

My view
Private · MENTOR takes it into account
−23.5%6M
Drag sideways across the chart to pick a period, or click an event's dot below it, then ask MENTOR about it.
26/10/2026Close 11.32+4.43%−23.5% since start

Key statistics

12 months to Jun 2026 unless a figure says otherwise

Profile

At the 26 Oct close
Market value
€718.8m
Enterprise valueDec 2025est.
€695.4m
Shares outstandingOct 2026
63.5m
Revenue12 months to Jun 2026
€603.6m
Employees
2,619
Traded a day, 3-month average
€710.1k

Valuation

12 months to Jun 2026
P/E
14.3×
P/B
1.8×
EV/Salesest.
1.2×
EV/EBITDAest.
7.9×

5 years, on reported full years: 7.8–16.3×, median 10.3×. Today 7.8×, lower than 98% of months.

P/FCFFY2022
60.9×
Dividend yield
3.5%

Margins

12 months to Jun 2026
Gross
37.1%
EBITDA
14.6%
Operating (EBIT)
10.8%
Pre-tax
10.5%
NetFY2025
8.9%
Free cash flowFY2022
2.7%

Net margin = the shareholders' profit ÷ group revenue.

Returns

FY2025
ROE
13.7%
ROCE12 months to Jun 2026
16.3%
ROIC12 months to Jun 2026est.
13.4%
ROA
8.4%
ROE, 5-year averageFY2021–25
11.4%
Tax rate
17.9%

Financial health

Dec 2025
Cash
€62.6m
Net debt
−€23.5m
Net debt ÷ EBITDA
−0.27×
Debt ÷ equity
15.4%

leases included

Interest coverFY2025
45.8×

Growth

Revenue, last yearFY2025
−0.1%
Revenue, last halfH1 2026
+1.3%
EPS, last yearFY2025
+17.0%
EPS, last halfH1 2026
−8.7%
Revenue, 3 yearsFY2022–25, a year
+10.4%
Revenue, 5 yearsFY2020–25, a year
+8.8%
EPS, 3 yearsFY2022–25, a year
+28.5%

Dividends

FY2025
Yield, last 12 months
3.5%
Per share
€0.395
Payout
47.4%
Years paid, last fiveFY2021–25
5

Trading and risk

From our closes, dividends reinvested
Total return, 1 year
−7.9%
3 years, a year
+16.7%
5 years, a year
+7.8%
10 years, a year
+11.6%
Volatility, 1 year
25.2%
Beta to the General Index
0.65×
Deepest fall, 1 year / 5 years
−30.7% / −34.1%
52-week range
€10.84–€15.64
est.worked out by usread with care: tap for why

Where the figures come from: the company's reports, reviewed by us · annual accounts filed in ESEF format · results announcements on the exchange · our own closing prices. No forecasts or target prices are stored.

Financial charts

From the stored figures: the reviewed dossier first, then the annual reports (ESEF) and results announcements

Loading the charts…

Valuation

vs PAP
MetricSARPAP
P/E14.318.2
P/B1.83.5
P/S1.21.1
EV/EBITDA7.99.5
Dividend yield3.5%3.0%
Payout ratio47.4%—
Gross margin37.1%32.5%
Operating margin10.8%—
Net margin8.9%7.8%
ROE13.7%—
Revenue growth (last full year)−0.1%20.6%
Net debt−€23.5m€18.4m
Twelve Data · latest quarter 30/06/2026

Peers: Personal & home care

EV/EBITDADay
SarantisSAR7.9+4.4%
PapoutsanisPAP9.5−0.9%
Compare in depth

The company

AI-drafted

Sarantis makes and distributes cosmetics, personal-care products and household consumables across thirteen European countries. It sells its own and third-party brands through retail chains, pharmacies and wholesalers. It operates production sites in Greece, Poland and Ukraine. The Sarantis family controls 60.35%.

How it makes moneyH1 2026 · basis: revenue
  • Home Care Solutions230.8%
  • Strategic Partnerships224.3%
  • Beauty, Skin & Sun Care2,1(seasonally high in the first half; 12.2% in FY2025)17.5%
  • Personal Care216%
  • Private Label2(now includes private-label sales outside Poland)11.4%
It is
  • A maker and distributor of cosmetics, personal-care and household products, with 73.5% of H1 2026 sales outside Greece and Poland its largest market.2
  • Family-controlled: the Sarantis siblings hold 60.35% and vote together under a 1997 agreement.1
  • Lightly geared: net debt of €29.6m at 30 June 2026 against FY2025 EBITDA of €89.0m.2,1
It is not
  • Not a cosmetics-only company: garbage bags, foil, film and private label made up 42.8% of FY2025 sales.1
  • No longer Estée Lauder's partner: it sold its 49% of the ELCA joint venture in 2022 for €55.2m.3
  • Not a retailer: it sells to chains, pharmacies and wholesalers, which resell to consumers.1
Recent developmentsAll company events →
  • Jul 2026Alpha Bank approved a €120m credit facility for general corporate purposes, undrawn at 8 September.2
  • Jun 2026Polipak sold its former, idle factory in Poland for €3.1m, with a €0.8m charge to results.2
  • Apr 2026The AGM approved a €25.0m dividend for 2025, up 25%, and a new buyback of up to 10% of the shares until April 2028.4,2
  • Feb 2026Took over exclusive distribution of Orkla's Jordan oral-care range in Greek pharmacies.2
  • Dec 2025The board was cut to eight members, half of them independent, as the CFO and HR chief left it while keeping their roles.1
  • Jun 20253,150,563 treasury shares were cancelled, cutting the share count to 63.7m and lifting the family's stake to 60.35%.1
Key figures
  • Net sales €308.3m H1 20262
  • EBITDA margin 15.5% H1 20262
  • Sales outside Greece 73.5% H1 20262
  • Net debt €29.6m H1 20262
  • Net profit €53.1m FY20251
Key facts
  • The Sarantis siblings held 60.35% at the last detailed disclosure; FMR LLC reached 10.00% of voting rights in September 2026.1,7
  • In March 2026 management guided to 2026 sales of about €620m and EBITDA of about €97m; at the half-year it did not reiterate the sales or EBITDA forecasts, while the capex budget rose to €22m.8,5,6
  • The remuneration policy approved in April 2026 sets an organic EBITDA target of €120m for 2028.4
  • Alpha Bank approved a €120m credit facility in July 2026, undrawn as of September.2
  • A final €20.6m instalment from the sale of the ELCA stake is due in January 2028.2
Sources
  1. 1.Annual Financial Report 2025 (ESEF)GR. SARANTIS S.A. · 11/03/2026official
  2. 2.Semi-Annual Financial Report H1 2026GR. SARANTIS S.A. · 08/09/2026official
  3. 3.Annual Financial Report 2022 (AnnualReports.com mirror)GR. SARANTIS S.A. · 27/03/2023
  4. 4.Resolutions of the AGM of 20 April 2026GR. SARANTIS S.A. · 20/04/2026official
  5. 5.H1 2026 Consolidated Financial Results, news releaseGR. SARANTIS S.A. · 08/09/2026official
  6. 6.H1 2026 financial results presentationGR. SARANTIS S.A. · 09/09/2026official
  7. 7.FMR LLC reaches 10% of voting rightsGR. SARANTIS S.A. · 24/09/2026official
  8. 8.FY2025 financial-results conference-call transcriptGR. SARANTIS S.A. · 12/03/2026official
AI-drafted from the cited sources · 30/09/2026 · v2 · ✓ checked by an independent second modelSarantis S.A.Website ↗
MENTORFree beta
Why it moved
+4.43% · volume 0.5×
News & events
News and what's next
Peers
No listed peers
Results
How it did vs last year
Valuation
No listed peers
More
Asks“What drove the 4.43% gain in Sarantis?”
Data: Twelve Data · End-of-day prices · Nothing here is investment advice.